I.G. Investment Management’s AstraZeneca AZN Stock Holding History

I.G. Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.97M	Buy	29,000 +4,000	+16%	+$253K	0.01%	251
2017 Q2	$1.71M	Buy	+25,000	New	+$1.63M	0.01%	278
2015 Q1	–	Sell	-31,087	Closed	-$2.19M	–	865
2014 Q4	$2.19M	Sell	31,087 -1,448	-4%	-$104K	0.01%	475
2014 Q3	$2.32M	Buy	32,535 +5,628	+21%	+$412K	0.01%	446
2014 Q2	$2M	Buy	26,907 +2,207	+9%	+$160K	0.01%	482
2014 Q1	$1.6M	Buy	24,700 +400	+2%	+$25.8K	0.01%	485
2013 Q4	$1.44M	Buy	24,300 +3,500	+17%	+$190K	0.01%	502
2013 Q3	$1.08M	Buy	+20,800	New	+$1.04M	﹤0.01%	558

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

I.G. Investment Management's AZN Position: Q3 2017 in Review

I.G. Investment Management increased its AstraZeneca (AZN) stake by 16% in Q3 2017, buying an estimated $253K and bringing the position to 29,000 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #251.

I.G. Investment Management first reported a position in AZN in Q3 2013 and has held it in 8 quarters since. The position peaked at $2.32M in Q3 2014. 455 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

I.G. Investment Management held 29,000 shares of AstraZeneca worth $1.97M as of Q3 2017.
I.G. Investment Management bought 4,000 AstraZeneca shares in Q3 2017, an estimated $253K.
AstraZeneca made up 0.01% of I.G. Investment Management's portfolio in Q3 2017, its #251 holding.
I.G. Investment Management first reported a position in AstraZeneca in Q3 2013 and has held it in 8 quarters since.
I.G. Investment Management's AstraZeneca position peaked at $2.32M in Q3 2014.
455 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.